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Abstract
Background: In pregnancy, maternal serum concentrations of calcitriol significantly rise as a result
of increased renal and placental contribution in order to assure calcium supply for the developing
fetus. Considering that placenta is a site for vitamin D activation, and the versatility and potency of
calcitriol, it is feasible that this hormone participates in fetal/placental development and physiology.
In the present work we studied calcitriol actions upon human chorionic gonadotropin (hCG)
secretion and expression in cultured trophoblasts, as well as vitamin D receptor (VDR) and
CYP27B1 immunolocalization in placental villi.
Methods: Quantification of hCG in culture media was performed by immunoassay. Expression
studies were carried out by real time PCR. Analysis of CYP27B1 and VDR localization in placental
slides were performed by immunohistochemistry. Statistical significance was established by one
way ANOVA using Tukey test for comparisons.
Results: Calcitriol regulated hCG in a time-dependent manner: at 6 h the secosteroid stimulated
hCG, whereas longer incubations (24 h) showed opposite effects. Interestingly, calcitriol
stimulatory effects on hCG were accompanied by an increase in intracellular cAMP content and
were abolished by pre-incubation of the cells with a selective protein kinase A inhibitor.
Immunohistochemical techniques showed differential VDR localization in the syncytiotrophoblast
layer or in the vascular smooth muscle cells depending on the epitope to which the antibodies were
raised (specific for the carboxy- or amino-terminal regions, respectively). CYP27B1 was
immunolocalized in the syncytiotrophoblast layer of placental villi.
Conclusion: The presence and location of the vitamin D activating enzyme CYP27B1 as well as
the specific receptor for vitamin D were shown in placental sections. The latter, together with
findings demonstrating specific effects of calcitriol acting through the VDR and the cAMP/PKA
signaling pathway upon hCG expression and secretion, indicate that there is a functional vitamin D
endocrine system in the placenta, and recognize calcitriol as an autocrine regulator of hCG.
Published: 22 January 2008
Reproductive Biology and Endocrinology 2008, 6:3 doi:10.1186/1477-7827-6-3
Received: 16 November 2007
Accepted: 22 January 2008
This article is available from: http://www.rbej.com/content/6/1/3
© 2008 Barrera et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Reproductive Biology and Endocrinology 2008, 6:3 http://www.rbej.com/content/6/1/3
Page 2 of 8
(page number not for citation purposes)
Background
Vitamin D is metabolized to the steroid hormone 1,25-
dihydroxyvitamin D3 or calcitriol, which regulates cal-
cium homeostasis, modulates the immune response, and
promotes cellular differentiation, among other actions.
Calcitriol, the most active vitamin D metabolite, exerts its
biological effects by binding to the vitamin D receptor
(VDR), which is a ligand-activated transcription factor
that recognizes cognate vitamin D response elements
(VDREs) in target genes, and can also elicit rapid
responses mediated by membrane receptors [1]. Placenta
is a source and target of calcitriol [2]. In a similar manner
to the renal process, placental production of calcitriol is
catalyzed by the mitochondrial CYP27B1 [3]. In early
reproductive events, calcitriol has shown to evoke specific
biological effects such as regulation of the decidualization
and implantation processes [4,5]. In addition, calcitriol
regulates placental lactogen expression as well as proges-
terone and estradiol secretion in cultured human syncyti-
otrophoblasts [6,7]. Regarding other molecules that are
regulated by calcitriol in the placenta, Evans et al showed
that calcitriol acts in an autocrine/paracrine fashion to
regulate both acquired and innate immune responses,
decreasing synthesis of cytokines such as granulocyte-
macrophage colony stimulating factor 2, tumor necrosis
factor, and interleukin 6, but increasing expression of
mRNA for the cathelicidin antimicrobial peptide [8].
Since human chorionic gonadotropin (hCG) is a pivotal
hormone for pregnancy maintenance, the aim of the
present work was to broaden the knowledge of calcitriol
actions in the placenta, focusing in the study of its effects
upon hCG expression and secretion in cultured human
syncytiotrophoblasts. The data presented herein display a
functional vitamin D endocrine system present in human
placenta and suggest its involvement in regulating placen-
tal physiology.
Methods
Reagents
Culture media, fetal bovine serum (FBS) and Trizol were
from Invitrogen (NY, USA). TaqMan Master reaction, Taq-
Man probes and the transcriptor RT system were from
Roche (Roche Applied Science, IN, USA), calcitriol
(1α,25-dihydroxycholecalciferol) was kindly donated
from Hoffmann-La Roche Ltd (Basel, Switzerland). 3-Iso-
butyl-1-methylxanthine (IBMX), 8-Bromo cAMP (8-Br-
cAMP), H-89 and the enzymes used for cell cultures were
from Sigma-Aldrich (MO, USA). Immunoassay for hCG
was from Immunometrics Ltd, (London, UK). CYP27B1
antibody (sheep anti-murine 25-hydroxyvitamin D-1α-
hydroxylase) was from The Binding Site (Birmingham,
UK). The VDR antibodies (rabbit polyclonal anti-VDR N-
20 sc-1009 and anti-VDR C-20 sc-1008), as well as the sec-
ondary antibodies rabbit anti-sheep-horseradish peroxi-
dase, and mouse anti-rabbit IgG-HRP were purchased
from Santa Cruz Biotechnology (CA, USA). DAB (3,3'-
diaminobenzidine tetrahydrochloride) was from Zymed
Laboratories Inc. (CA, USA).
Immunohistochemistry
This study was approved by the Institutional Human Eth-
ical Committee (Hospital de Gineco-Obstetricia "Luis
Castelazo Ayala", IMSS, México), and written informed
consents forms were obtained from each placental donor.
Term placentae (37–42 weeks of gestation) were acquired
from uncomplicated pregnancies.
Fresh placental tissue from 5 term placentas was embed-
ded in paraffin after fixation in 4% paraformaldehyde in
0.1 M phosphate buffer, pH 7.4. Serial sections (7 μm)
were obtained according to standard procedures. Slides
were treated with methanol-hydrogen peroxide in order
to block the endogenous peroxidase activity. Normal rab-
bit serum and 1% BSA were used as blockers to decrease
non-specific signal. Slides were then incubated with pri-
mary antibodies (anti-CYP27B1, anti-VDR-N and anti-
VDR-C) during 45 minutes at room temperature, fol-
lowed by further washing and incubation with secondary
antibodies for another 45 minutes. Staining was devel-
oped using DAB substrate and the chromogen was con-
trasted with Mayer's hematoxylin. Immunolabeling
specificity was tested by omitting the primary antibody.
Trophoblast cell culture
Trophoblasts were cultured as previously described
[3,9,10]. Briefly: Villous cytotrophoblasts were obtained
by enzymatic dispersion and cells were separated on den-
sity Percoll gradients. Trophoblasts were plated at a den-
sity of 8 × 105  cells/mL in supplemented medium
[(DMEM) 100 U/ml penicillin, 100 mg/ml streptomycin,
0.25 mg/ml Fungizone], containing 20% heat-inactivated
FBS. Incubations were performed in humidified 5% CO2-
95% air at 37°C. The morphological aspects of cells were
examined daily, secreted hCG was measured by immu-
noassay (EIA) following manufacturer instructions and
results were normalized against total protein content. Pro-
tein was determined by the method of Bradford [11].
Calcitriol effects on hCG secretion
Two days-cultured trophoblasts were incubated in the
presence of different concentrations of calcitriol or etha-
nol as vehicle, in serum-free DMEM-F12 during 6 h or 24
h. Additional experiments were performed incubating the
cells with a selective protein kinase A inhibitor (H-89).
Incubations were stopped by media collection, cell lysis
with RIPA buffer (9.1 mM dibasic sodium phosphate, 1.7
mM monobasic sodium phosphate, 150 mM NaCl, 1%
Nonidet P-40, 0.1% SDS, pH 7.4) was used for protein
determination and hCG was quantified in culture media.Reproductive Biology and Endocrinology 2008, 6:3 http://www.rbej.com/content/6/1/3
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Calcitriol effects on hCG expression
For expression studies 3 × 106 cells were plated in 25 cm2
cell culture flasks and subjected to the same treatments as
stated above. Total RNA was extracted using Trizol and 1
μg was reverse transcribed using the transcriptor RT sys-
tem. Real-time PCR was carried out using the LightCycler
2.0 from Roche (Roche Diagnostics, Mannheim, Ger-
many), according to the following protocol: activation of
Taq DNA polymerase and DNA denaturation at 95°C for
10 min, proceeded by 45 amplification cycles consisting
of 10 s at 95°C, 30 s at 60°C, and 1 s at 72°C. The primer
pair was targeted to the β subunit of the hCG mRNA and
the sequences were as follows: GCTCACCCCAGCATC-
CTAT and CAGCAGCAACAGCAGCAG. The house keep-
ing gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was also amplified as an internal control, using
the primers: AGCCACATCGCTGAGACAC and
GCCCAATACGACCAAATCC. The sizes of the resulting
amplicons were 131 bp and 66 bp, and the probes utilized
were # 79 and # 60 (Roche human universal probe
library), for hCG and GAPDH, respectively. The expres-
sion of CYP24A1 used as a control for calcitriol effects was
evaluated using the following sense and anti-sense prim-
ers: CATCATGGCCATCAAAACAA and GCAGCTCGACT-
GGAGTGAC and probe # 88 from Roche human universal
probe library.
Calcitriol effects on cAMP accumulation
Cells were incubated in the presence of calcitriol or its
vehicle in DMEM-F12 supplemented with IBMX (0.05
mM). Incubations were terminated after 10 minutes by
media collection and homogenization of the cells in RIPA
buffer. Samples were boiled during 5 min for phosphodi-
esterases inactivation and intracellular cAMP was meas-
ured by specific radioimmunoassay (RIA) as previously
described [12]. Results were normalized against total pro-
tein content and expressed as fmol cAMP/mg protein.
Statistical analysis
Data are presented as the mean ± S.D. Statistical signifi-
cance among groups was established by one way ANOVA
using Tukey test. A P value ≤ 0.05 was considered statisti-
cally significant.
Results
Immunohistochemical studies
Analysis of sequential placental tissue sections indicated
the presence of immunoreactive CYP27B1 in the syncyti-
otrophoblast layer (Fig. 1A). A similar immunostaining
pattern for VDR was visualized using an anti C-terminus
specific antibody, immunostaining was also identified in
vascular smooth muscle cells (VSMC, Fig. 1C). Interest-
ingly, the use of an anti N-terminus VDR specific antibody
disclosed intense immunostaining in the VSMC, and
weak signal in the syncytiotrophoblast layer was observed
(Fig. 1E). Control incubations without primary antibod-
ies are shown in figure 1B, D and 1F. These results demon-
strated the presence in the placenta of two important
components of the vitamin D endocrine system. Consid-
ering these data, we searched for a marker of placental
function. Since trophoblast cell culture has proven to be a
good model to study placental physiology and hCG is a an
important marker of placental functionality, we decided
to use this system in order to evaluate calcitriol regulatory
actions at the placental level.
Calcitriol effects on hCG in cultured trophoblasts
Cultured purified cytotrophoblasts aggregated and
formed syncytia in a time dependent manner. Cell culture
viability was evaluated by measurements of hCG in the
presence or absence of 8-Br-cAMP, an analog of cAMP, a
well known regulatory factor of hCG expression [13,14].
Basal secretion of hCG into the culture media increased
during the cytodifferentiation process, and cells cultured
in the presence of 8-Br-cAMP secreted significantly more
hCG than controls (Fig. 2A). Similarly, hCGβ mRNA
increased with the same pattern observed under basal
conditions (Fig. 2B), and in the presence of 8-Br-cAMP the
highest hCGβ gene expression was observed on day 2,
which preceded the maximal hCG secretion on day 3.
These data, in addition to morphological cell evaluation,
further confirmed the functional integrity of the primary
culture system.
In the presence of calcitriol, hCG secretion increased sig-
nificantly after 6 hours of incubation (Fig. 3A). Calcitriol
also upregulated hCGβ mRNA (Fig. 3B). Since hCG is
highly regulated by the cAMP/PKA pathway, and calcitriol
has shown to induce cAMP accumulation [12,15], we
investigated the participation of this second messenger
upon hCG-upregulation by calcitriol. For this purpose,
cAMP was quantified in calcitriol-incubated cells. Results
indicated that after 10 minutes of treatment, the secoster-
oid significantly increased intracellular cAMP content in a
dose-dependent manner (Fig. 4A). Preincubation of cells
with a selective inhibitor of PKA (H-89) reduced hCG
expression below basal levels and prevented the calcitriol-
dependent protein and gene hCG-stimulation detected at
the 6 h incubation period (Fig. 4B and 4C, respectively).
The same results were obtained in 72 h cultures (data not
shown).
Calcitriol long-term effects upon hCG were also studied.
The stimulatory effects observed at 6 h were no further evi-
dent after 24 h (data not shown), and when cells were
incubated in the presence of calcitriol during 2 consecu-
tive days, the effects were rather inhibitory (Fig. 5A). Inhi-
bition was evident at the mRNA level after 24 hours
treatment (Fig. 5B), preceding the observed response in
hCG protein. This repressive calcitriol effect could not beReproductive Biology and Endocrinology 2008, 6:3 http://www.rbej.com/content/6/1/3
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Immunolocalization of CYP27B1 and VDR in placental chorionic villi Figure 1
Immunolocalization of CYP27B1 and VDR in placental chorionic villi. Placental sections were incubated with specific antibodies 
in order to localize important components of the vitamin D endocrine system. CYP27B1 protein was located in the syncytio-
trophoblast layer (A). The use of anti N-terminus VDR specific antibody disclosed intense immunostaining in the VSMC (E), 
whereas a VDR-C-terminus antibody preferentially stained the syncytiotrophoblast layer (C). Figure shows representative pic-
tures of 5 different placentas. Negative controls in the absence of first antibodies are shown in B, D and F. SC = syncytiotro-
phoblast layer, VSMC = vascular smooth muscle cells, RBC = red blood cells. (200×).
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attributed to decreased cell viability, since under the same
conditions, calcitriol upregulated CYP24A1 gene expres-
sion (Fig. 5C).
Discussion
Serum concentrations of biologically active hCG depend
on the rate of synthesis of its specific β subunit; whereas at
the cellular level multiple factors modulate hCG produc-
tion by interacting with specific membrane receptors on
placental trophoblasts. The most studied factors that
modulate hCG are the gonadotropin releasing hormone
(GnRH), hCG itself and other molecules that activate
cAMP-dependent signal transduction pathways [16-18].
Indeed, both hCGα and hCGβ genes are highly transcrip-
tionally induced by cAMP [19-21]. In this study we
showed that calcitriol is an additional factor that modu-
lates hCG in human trophoblasts. In fact, calcitriol regu-
lated hCG in a time-dependent manner, stimulating or
inhibiting hormone secretion and expression. The stimu-
latory effect after 6 hours was probably due, as demon-
strated in this study, to the rapid calcitriol-dependent
increase in intracellular cAMP. This assumption was fur-
ther supported by results in the presence of H-89, a selec-
tive inhibitor of PKA. Indeed, blocking the cAMP/PKA
Stimulatory effects of calcitriol on hCG secretion and gene  expression in cultured syncytiotrophoblasts Figure 3
Stimulatory effects of calcitriol on hCG secretion and gene 
expression in cultured syncytiotrophoblasts. A) Hormone 
secretion was determined by EIA after 6 hours incubation in 
the presence of increasing concentrations of calcitriol or its 
vehicle (-). B) Real time PCR analysis of hCGβ gene expres-
sion of calcitriol-treated cells. Results were normalized 
against GAPDH mRNA. Vehicle data were arbitrarily given a 
value of 1. Each bar represents the mean ± S.D. of triplicate 
cultures. *P < 0.05 vs. control.
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Temporal pattern of hCG secretion (A) and expression (B)  in cultured human trophoblasts Figure 2
Temporal pattern of hCG secretion (A) and expression (B) 
in cultured human trophoblasts. Cytotrophoblasts were 
plated in the absence ( ) or presence ( ) of 8-Br-cAMP (1.5 
mM). Two scale bars were used in order to show all data 
[stimulated ( ) vs. non stimulated ( )] in the same graphic. 
Media was changed every day. A) Secretion of hCG in culture 
media was measured daily and results were expressed as 
mIU/mg protein. B) Real time PCR analysis of hCGβ expres-
sion in different culture days. Results were normalized 
against GAPDH mRNA. Vehicle data were arbitrarily given a 
value of 1. Basal hCG secretion and expression increased sig-
nificantly compared with day 1. Note that hCGβ mRNA 
increased considerably on day 2 in the presence of 8-Br-
cAMP (B), which was reflected on hCG secretion on day 3 
(A), showing an important protein synthesis activity between 
day 2 and 3 of the cell culture. Data are presented as the 
mean ± S.D. of three different cell cultures. *P < 0.05 vs. day 
1; **P < 0.05 vs. control.
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signal transduction cascade impaired the ability of calci-
triol to elicit transcriptional induction of hCGβ gene, as
well as hCG secretion into the culture media. Rapid cAMP
generation induced by calcitriol has been previously
reported in other cell types [15,22], and may be the result
of its interaction with membrane-VDR or other surface
proteins. In addition, since it has been demonstrated that
calcium ion channels are involved in GnRH dependent-
hCG secretion [23], calcitriol could also release stored
Long-term inhibitory effects of calcitriol on placental hCG Figure 5
Long-term inhibitory effects of calcitriol on placental hCG. 
A) hCG concentration in culture medium was determined 
after 2 days incubation in the presence of increasing concen-
trations of calcitriol or the vehicle alone (-). B) Real time 
PCR analysis of hCGβ gene expression in calcitriol-treated 
cells after 24 h. Results were normalized against GAPDH 
mRNA, vehicle data were arbitrarily given a value of 1. C) 
CYP24A1 mRNA induction by calcitriol after 24 h. Results 
were normalized against GAPDH mRNA. Vehicle data were 
arbitrarily given a value of 1. The inhibitory effects of calci-
triol upon hCG gene expression detected after 24 h (B) were 
reflected in a reduction of secreted hCG after 48 h (A). 
These effects were not due to a toxic effect of calcitriol since 
cells showed increased CYP24A1 gene expression, as 
expected (C). Each bar represents the mean ± S.D. of tripli-
cate experiments. *P < 0.05 vs. control.
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Calcitriol stimulatory effects on hCG involve cAMP Figure 4
Calcitriol stimulatory effects on hCG involve cAMP. A) 
Dose-dependent effects of calcitriol upon intracellular cAMP. 
Quantification of intracellular cAMP was determined by RIA 
after 10 minutes incubation in the presence of increasing 
concentrations of calcitriol or the vehicle (-). Effects of H-89 
(a selective PKA inhibitor) upon calcitriol-dependent stimula-
tion of hCG secretion and gene expression are shown in B 
and C, respectively. B and C) Cells were incubated with calci-
triol (1 × 10-9 M) in the presence or absence of H-89 (5 μM) 
during 6 hours. In panel B, calcitriol incubations in the 
absence of H-89 represent 100% stimulation. In panel C 
results were normalized against GAPDH mRNA, giving vehi-
cle data an arbitrarily value of 1. Each bar represents the 
mean ± S.D. of triplicate experiments. *P < 0.05 vs. control.
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hCG through promoting a rapid calcium entry into the
cell. Further studies are needed in order to clarify this mat-
ter.
The concentration of hCG was also measured after 12, 24
and 48 h of calcitriol treatment, but the results reported in
the present study were only those that differed signifi-
cantly when compared with the vehicle alone. The stimu-
latory effects observed at 6 h were no further evident after
12 or 24 h, and when cells were incubated in the presence
of calcitriol during 2 consecutive days, the effects were
rather inhibitory. Inhibition was evident at the mRNA
level after 24 hours treatment, preceding the observed
response in hCG protein. These data are probably more
likely to be reflective of the true biological situation.
Indeed, our results that calcitriol inhibited hCG were in
line with previous data from this and other laboratories
where low serum calcitriol and high serum hCG levels
were found in preeclampsia [24-26], that conjointly with
the fact that [3H]25-hydroxyvitamin D bioconversion into
[3H]1,25-dihydroxyvitamin D was significantly reduced
in preeclamptic placentas [9], may suggest a direct regula-
tory effect of calcitriol on hCG production. Regarding the
inhibitory effects of calcitriol on hCG, it is likely that a sec-
ondary metabolic C23/C24 calcitriol oxidation pathway
might play a role, since the resulting trihydroxylated
metabolite is considered biologically inactive [1]. Alterna-
tively, since calcitriol has been shown to stimulate proges-
terone secretion [6] and in turn this hormone inhibits
hCG secretion [27], this mechanism could additionally
participate in calcitriol long term inhibitory effects in pla-
centa. In any case, the demonstration in this study of
genomic mediated effects of calcitriol on hCG suggested
the presence of VDR dependent regulatory regions on
hCG promoters. Indeed we found five putative VDR/RXR
heterodimer binding sites in the hCGβ-5 gene promoter
[28], which probably may be acting as calcitriol depend-
ent-transcriptional regulatory regions. Nevertheless, the
sole presence of the VDREs in the hCGβ-5 promoter is not
sufficient to indicate transcriptional function; therefore,
functional evaluation of the putative VDREs deserves fur-
ther investigation.
In non pregnant women the physiological concentration
of calcitriol fluctuates between 40–100 pM. In the present
study the calcitriol doses tested were: 100 pM, 1 nM and
10 nM. The lowest concentration (100 pM) is within the
physiological range of circulating calcitriol levels in mexi-
can pregnant women (127 pM and 151 pM) as observed
previously [24,29]. The other doses tested were supra-
physiological, nevertheless, calcitriol effects upon hCG
were evident starting with the lowest concentration.
Placenta is considered not only as a source but also as a
target of calcitriol [2]. In order to get insights on calcitriol
paracrine/autocrine effects in placenta, we investigated
the immunolocalization of VDR and CYP27B1 in placen-
tal chorionic villi. In accordance with previous reports
[30], CYP27B1 protein was located in the syncytiotro-
phoblast layer, corroborating that the endocrine pheno-
type of trophoblasts cells is responsible for vitamin D
activation in placenta. To answer where the locally pro-
duced calcitriol acts in the placenta, we looked for VDR
protein in placental sections. To our knowledge, this is the
first report to show immunoreactive VDR in different
locations in the placental villi, since VDR expression has
been mainly addressed at the mRNA level in placenta
[2,31]. The antibodies showed the presence of VDR in the
endocrine placental cells and VSMC, suggesting that calci-
triol could be involved in regulating hormonal produc-
tion and vascular remodeling through the VDR. The latter
assumption derives from previous studies demonstrating
that calcitriol acts in the vasculature promoting VSMC
growth and migration [32,33]. Interestingly, the C-termi-
nus antibody intensely stained the syncytiotrophoblast
layer and faintly stained the surrounding cells of placental
vessels, whereas the N-terminus antibody detected a
strong signal in the endothelial and VSMC. These observa-
tions may indicate different epitopes recognized by the
antibodies depending on the topological position of the
VDR. An interesting challenge would be to define specific
VDR responses in different placental structures.
Conclusion
In summary, the present study broadens the knowledge of
placental vitamin D endocrine system by demonstrating
the physiological effects of calcitriol on an important bio-
chemical placental function marker such as hCG. In addi-
tion, this is the first report to show immunoreactive VDR
in different locations in human placental villi, and opens
the field to address important research questions on the
role of calcitriol in specific placental structures.
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